STAT3 and breast cancer: Bioinformatics, small molecule inhibitor, inducible CRISPR/Cas9 KO, and overexpression experiments strongly implicate STAT3 and p300 as mechanotransducers during breast cancer (Supplementary Figs. 10 and 11).